Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Can tigecycline's liver metabolism cause dosage changes?

See the DrugPatentWatch profile for tigecycline

Short answer: No. Tigecycline's dosing is not driven by liver metabolism.

Why:
- Tigecycline is not significantly metabolized by the liver. It is eliminated mainly as unchanged drug via biliary/fecal routes.
- Because of this, hepatic impairment generally does not require a dose adjustment. The usual adult dosing (loading 100 mg IV, then 50 mg IV every 12 hours) is used without modification for hepatic impairment in most labeling.

Notes:
- Data in severe hepatic impairment (eg, Child-Pugh C) are limited, but current guidance does not require a routine dose reduction.
- If there are other complicating factors (severe cholestasis, critical illness, drug interactions), consult the prescribing information or a clinician.

If you want, I can pull up the exact labeling language or summarize any specific hepatic impairment scenarios.



Other Questions About Tigecycline :

Should antacids be taken with tigecycline medication? Can antacids reduce tigecycline s antibacterial potency? Does tigecycline s resistance profile differ from generic alternatives? How does tigecycline misuse impact treatment duration? How effective is tigecycline injection generic compared to alternatives? Which policies hindered tigecycline usage? How does tigecycline misuse affect patient outcomes?